FDA commits to high safety standards in coronavirus vaccine review

Published October 22, 2020 10:32pm ET



The Food and Drug Administration’s coronavirus vaccine advisory panel assured the public that the approval process will uphold the highest safety standards to boost confidence.

“Only those vaccines that are demonstrated to be safe and effective” will be licensed by the FDA, said Marion Gruber, director of the FDA’s Office of Vaccines Research and Review.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.